Latest Ginkgo Bioworks News & Updates

See the latest news and media coverage for Ginkgo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ginkgo Bioworks (Ginkgo)

Autonomous lab platform for biotechnology R&D

ginkgo.bio

Headquarters: Boston, United States
Company type: Public company
Number of employees: 500–1,000

Last updated Today

Latest news about Ginkgo Bioworks (Ginkgo)

In short: Ginkgo implemented major cost-cutting measures, including workforce reductions and biosecurity divestitures, to focus on its autonomous lab platform.

Company announcements

May 7 Ginkgo

Ginkgo reports Q1 2026 results, completes biosecurity divestiture

Revenue fell to $19M from $38M, net loss narrowed to $76M, and Nebula lab expansion targets doubling size.

April 30 Ginkgo

Ginkgo announces first quarter 2026 results presentation date

The presentation and Q&A session will be on May 7, 2026 after market close.

February 26 Ginkgo

Ginkgo reports Q4 and FY2025 financial results and plans divestiture

Revenue decreased 24% in Q4 to $33M, and the company will sell its biosecurity business to focus on autonomous labs, with a $47M contract won.

February 19 Ginkgo

Ginkgo announces Q4 and full year 2025 results presentation date

The presentation and Q&A will be held on February 26, 2026 after market close.

Media coverage

May 8 AAII

Why Ginkgo Bioworks Holdings, Inc.'s (DNA) Stock Is Down 13.95%

As of Friday, May 08, Ginkgo Bioworks Holdings, Inc.'s DNA share price has dipped by 13.95%, which has investors questioning if this is right time...

March 2 Morningstar

Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

BOSTON, March 2, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to...

5 November 2025 Genetic Engineering and Biotechnology News

Ginkgo Bioworks Awarded Project Agreement Through BARDA’s BioMaP-Consortium

Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium).

29 August 2025 Seeking Alpha

Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions

A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF...

Never miss news about Ginkgo

Track Ginkgo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.